Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptors (ER) and progesterone receptors (PR) expression, and the absence of the overexpression of the human epidermal growth factor receptor 2 (HER-2). The gene discussed is PGR; the disease is triple-negative breast carcinoma.